| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Psychosomatic Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan; Kuma Hospital Kobe, Japan;
Department of Internal Medicine, School of Medicine, University of California-Davis Davis, California;
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo Tokyo, Japan
TRH tests were performed in 206 clinically and biochemically euthyroid relatives of patients with Graves' disease. In 117 of the 206, T3 suppression tests were performed. Results revealed that 56 of the 206 (27.1%) showed abnormal responses to TRH. Twenty-nine of these (14.1%) revealed absent or decreased responses, and 27 (13.1%) revealed augmented responses to TRH. Eight of the 117 (6.8%) were T3 nonsuppressible. These eight subjects consisted of 4 subjects out of 17 hyporesponders and 4 subjects out of 90 normal responders. The majority of suppressible subjects (86 among 109) demonstrated normal responses to TRH. Sixty-nine of the 206 subjects were followed for 6 months to 5 yr to observe changes in their thyroid functions. Among all 69 subjects, 3 became clinically thyrotoxic 12, 12, and 18 months after their initial visit, respectively, and 2 became clinically hypothyroid 2 yr after their initial visit. Since 69 subjects were clinically and biochemically euthyroid and had no goiter or exophthalmos at their initial visit, the incidence of thyrotoxicosis or hypothyroidism in these subjects could be considered to be remarkably high. It is of interest that the 3 thyrotoxic patients were TRH hyporesponders at their first visit. One patient was T3 suppressible; T3 suppression tests were not performed in the other 2 patients at their initial visit. There was no abnormality in the first TRH test in 2 relatives who became hypothryoid.
It is suggested that 1) among euthyroid relatives with a family history of Graves' disease, there are many with abnormalities in TRH responsiveness and T3 suppressibility, 2) nonsuppressible subjects are more likely to be TRH hyporesponders and vice versa, 3) hyperthyroidism or hypothyroidism occurs frequently in euthyroid relatives with a family history of Graves' disease, and 4) thyrotoxicosis occurs frequently in TRH-hyporesponders, and hypothyroidism occurs in the others.
* This work was presented at the Eighth International Thyroid Congress, February 3-8, 1980, Sydney, Australia.
Received April 14, 1980.
This article has been cited by other articles:
![]() |
A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer Joint Genetic Susceptibility to Type 1 Diabetes and Autoimmune Thyroiditis: from Epidemiology to Mechanisms Endocr. Rev., October 1, 2008; 29(6): 697 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ban, D. A. Greenberg, T. F. Davies, E. Jacobson, E. Concepcion, and Y. Tomer 'Linkage Analysis of Thyroid Antibody Production: Evidence for Shared Susceptibility to Clinical Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3589 - 3596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomer and T. F. Davies Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function Endocr. Rev., October 1, 2003; 24(5): 694 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomer, D. A. Greenberg, G. Barbesino, E. Concepcion, and T. F. Davies CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1687 - 1693. [Abstract] [Full Text] |
||||
![]() |
G. Barbesino, Y. Tomer, E. S. Concepcion, T. F. Davies, and D. A. Greenberg Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease. II. Selected Gender-Related Genes and the X-Chromosome J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3290 - 3295. [Abstract] [Full Text] |
||||
![]() |
G. Barbesino, Y. Tomer, E. Concepcion, T. F. Davies, and D. A. Greenberg the International Consortium Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease: 1. Selected Immunoregulatory Genes J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1580 - 1584. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |